Skip to content

Management of Non Progressive Pterygium

A clinical study to evaluate the efficacy of Chandanadichurna Anjana along with Shatavaryadi Churna in the management of Shukla Arma (Non- Progressive Pterygium) - Nil

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/03/083155
Enrollment
30
Registered
2025-03-24
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H110- Pterygium of eye

Interventions

None listed

Sponsors

Institute for Ayurved Studies and Research
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. The person with age of 20-60years. 2. Patients with sign and symptoms of Shukla Arma (Non-progressive pterygium) will be selected irrespective of Sex, Religion and Profession. 3. Clinical Features like White Fleshy Growth in Suklamandalam white portion of eyes), foreign body sensation, and watering of eyes. 4. Patients those are fit for Anjana Karma according to Ayurveda text. Patient willing to register for trial.

Exclusion criteria

Exclusion criteria: 01. Age less than 20 years and more than 60 years 02. Anjana Ayogya 03. Progressive pterygium 04. The patients in which Pterygium covers the pupillary margin. 05. Prastari Arma, Lohita Arma, Adhimamsa Arma, Snayu Arma 06. Arma (fleshy mass on the white portion of eyes) with any other ocular pathologies like Abhisyanda, Adhimantha, etc. 07. Pseudopterygium 08. Chemical injury: e.g., Lime burn or any other 09. Chronic viral infections: e.g., Hepatitis C, HIV etc. 10. Neurological conditions: e.g., Parkinson disease, Bell’s palsy, Trigeminal neuralgia 11. Immunological diseases – Autoimmune disease, collagen vascular and immunodeficiency. 12. Pregnancy 13. Diabetes mellitus 14. Hyperlipidaemia 15. Hypertension 16. Patients not willing to be registered for trial.

Design outcomes

Primary

MeasureTime frame
Reduction in sign and symptoms of Shukla Arma (Non- progressive pterygium).Timepoint: 60 Days

Secondary

MeasureTime frame
Improvement in quality of life of patient.Timepoint: 60 DAYS

Countries

India

Contacts

Public ContactDr Amanveer Kour Chani

Institute for Ayurved Studies and Research

drashukataria@gmail.com9416553131

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026